Amerikaanse aandelen « Terug naar discussie overzicht

BioElectronics Cooperation (BIEL)

978 Posts, Pagina: « 1 2 3 4 5 6 ... 39 40 41 42 43 44 45 46 47 48 49 » | Laatste

Omlaag ↓

[verwijderd] 12 september 2009 15:59

Reden van stijging van gisteren ( zou kunnen zijn ):

Volgen diverse personen op het Yahoo forum is BIEL ge-update in de Pink-sheet, doordat ze alle benodigde informatie verstrekt hebben om aan een volwaardig OTC aandeel te voldoen.
Dit zien de grote "mannen" dus ook en geeft vertrouwen.

Link :
www.pinksheets.com/pink/quote/quote.j...

Type : Initial Company Information and Disclosure Statement

[verwijderd] 14 september 2009 15:07

Biel mag nu wel even gas terugnemen of een pas op de plaats doen. Wil graag nog een plukje bijkopen maar heb geen centen vrij momenteel...

Nou ben erg benieuwd wat de dag van vandaag en de rest van de week zal gaan brengen voor alle aanstaande bilionaires ;-)

Demenkovets 14 september 2009 22:09

quote:
elegal schreef:
Biel mag nu wel even gas terugnemen of een pas op de plaats doen. Wil graag nog een plukje bijkopen maar heb geen centen vrij momenteel...

Nou ben erg benieuwd wat de dag van vandaag en de rest van de week zal gaan brengen voor alle aanstaande bilionaires ;-)

Nou, uw wens is uitgekomen.. 12% eraf vandaag.

Aan dit nieuws heeft het niet gelegen..

BioElectronics Wins Wall Street Journal 2009 Innovation Award
BioElectronics' Portable PEMF Technology Is One of 3 Runner Ups in Medical Device Category

* Press Release
* Source: BioElectronics Corporation
* On Monday September 14, 2009, 10:00 am EDT
*
Companies:
o BioElectronics Corporation

FREDERICK, MD--(Marketwire - 09/14/09) - BioElectronics Corp. (Pinksheets:BIEL - News), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it has been selected as a runner up in the medical device category of the 2009 Wall Street Journal Innovation Awards unveiled in today's global editions and online. The award was given for the Company's wearable patch that uses pulsed electromagnetic energy to deliver drug-free pain relief for a variety of conditions.

Richard Staelin, Chairman of the Board of BioElectronics, said, "We are gratified that such a prestigious organization has validated the work of BioElectronics management to bring our innovative technology to market. For a start-up of our size, it is exciting to be on a winners list that includes this year established technology leaders like Abbot Labs, HP, Qualcomm, National Semiconductor, Intel and NASA. The Wall Street Journal said that they received almost 500 nominations from around the world and selected only 36 winners." A complete file of this year's winners is available on the WSJ Online website or on www.healfasttherapy.com/wsjinnovation...

Andrew Whelan, BioElectronics CEO, will accept the award at The Wall Street Journal's 2009 Technology Innovation Awards ceremony on Oct. 13 at a dinner in Redwood City, Calif. featuring a keynote address by Marc Benioff, chairman and chief executive of Salesforce.com Inc. The ceremony will be held in conjunction with the Dow Jones VentureWire Technology Showcase.

About BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch� Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (www.healfasttherapy.com ) and the Allay(TM) family (www.AllayPatch.com) of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see www.BioElectronicsCorp.com.

Image Available: www2.marketwire.com/mw/frame_mw?attac...

[verwijderd] 14 september 2009 22:17

erg jammer dat i zo down is gegaan

nog steeds een mooie koers, maar vrijdag was ie toch leuker ;-)

komt wel weer..

[verwijderd] 15 september 2009 14:47

vond ik ook. denk dat veel mensen hun winst gewoon pakte waar niks mis mee is natuurlijk. als ze maar elke week iets stijgen hoor je mij niet. ik verwacht wel dat ze ook deze week positief afsluiten.

[verwijderd] 17 september 2009 15:08

quote:
aldel schreef:
Kan het niet vinden bij abn, hoe dan wel??

informatie over de bio-electronics producten kan je in het nederlands vinden op www.jumatro.com, www.gezondheidsstad.nl, en je kan ze kopen op www.ge.zond.nl en binnenkort ook bij grote en bekende winkels en sites

[verwijderd] 22 september 2009 16:23

biel gaat er vandoor.
0,1051 0,014100 15,49%

er is nieuws.

[verwijderd] 22 september 2009 16:24

BioElectronics Files With FDA for OTC Pre-Marketing Clearance

[verwijderd] 22 september 2009 16:25

BioElectronics Files With FDA for OTC Pre-Marketing Clearance

* Press Release
* Source: BioElectronics Corporation
* On Tuesday September 22, 2009, 10:15 am EDT

o
Buzz up! 0
o Print

*
Companies:
o BioElectronics Corporation

FREDERICK, Md., Sept. 22, 2009 (GLOBE NEWSWIRE) -- BioElectronics Corp. (Pink Sheets:BIEL - News), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced that it filed today with the U.S. Government's Food and Drug Administration for 510(K) premarketing clearance for its ActiPatch(R) Therapy products. In this application BioElectronics will seek over-the-counter clearance of its ActiPatch Therapy products for the indication of general pain relief relative for general musculoskeletal complaints.
Related Quotes
Symbol Price Change
BIEL.PK 0.0899 -0.0011
Chart for BIOELECTRONICS CORP
{"s" : "biel.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""}

Arnon Horev, ActiPatch Brand Manager, commented, "Today's filing is the result of many years of hard work by not only the BioElectronics staff, but also many physician investigators who have worked tirelessly to complete our sponsored clinical trials. We believe the pre-marketing notification we put forth today is exceptionally strong and we have taken every effort to ensure it conforms to all FDA requirements. The product is already cleared for one indication by FDA and the clinical data we are submitting today shows strongly statistically significant efficacy and 100% safety. ActiPatch has already helped thousands of pain sufferers worldwide in dozens of countries without a single safety issue ever being raised and the product is already approved by Health Canada for the relief of musculoskeletal complaints and has CE Mark (European Common Market) Certification. Additionally, ActiPatch is available for sale over the counter in many other countries throughout the world. These users are clearly safely enjoying the benefits of our ActiPatch products."

BioElectronics intends to place the ActiPatch Therapy products for heel/foot, back, knee, wrist, and elbow pain on store shelves in the U.S. drug and grocery store channel upon FDA clearance. FDA clearance will also significantly enhance the marketability of the Company's products on a worldwide basis. The management team believes these markets are worth hundreds of millions of dollars per year. With very few products targeting these conditions having undergone the rigorous clinical trial and FDA clearance processes, BioElectronics believes its products will be highly differentiated relative to competing therapies.

Mr. Horev continued, "We have also taken the extra step of including usability studies in the notification we filed today as we believe this strongly enhances our case for over-the-counter clearance. In our usability studies, test subjects were easily able to understand our product directions and how to easily and safely use the ActiPatch. Our confidence level is high that FDA reviewers will agree that ActiPatch is a highly effective and safe drug-free pain relief alternative to Tylenol(R), Motrin(R) and other drug-based OTC and prescription therapies."

Andrew Whelan, CEO of Bioelectronics commented, "While it is clearly a very exciting time for all of us at BioElectronics and our shareholders, the management team has never lost sight of our main goal of providing the public a highly effective and safe method for relieving chronic pain and suffering. We believe our products do exactly this and we look forward to making our products generally available to an eager American public. Over the coming months we look forward to further building our brands, including the Allay(TM) Period Relief Patch and our surgical recovery product, RecoveryRX(TM), and filing additional pre-marketing clearance notifications with FDA."

About BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch(R) Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (www.healfasttherapy.com) and the Allay(TM) family (www.AllayPatch.com) of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see www.BioElectronicsCorp.com.

The BioElectronics Corporation logo is available at www.globenewswire.com/newsroom/prs/?p...

Contact:

BioElectronics Corp.
Joe Noel
(925) 922-2560

Buzz up! 0
Send
Share
Print
Share this page

*
Delicious
*
Twitter
*
Myspace
*
Digg
*
StumbleUpon
*
Facebook

Related Headlines

* BioElectronics Files With FDA for OTC Pre-Marketing Clearance - GlobeNewswire
* BioElectronics to Use Newswire.net Service - GlobeNewswire
* BioElectronics Wins Wall Street Journal 2009 Innovation Award - Marketwire
* A New Audio Interview with Andrew Whelan, CEO of BioElectronics, Inc., is now at SmallCapVoice.com - Business Wire
* BioElectronics Announces FDA 510(K) Filing Schedule - Marketwire

Related Blog Headlines

* Stock Watch: CSUH.OB, MHTX.OB, BIEL.PK, SPHRY.PK - at Seeking Alpha
* As Market Drops, It's Time to Buy - at Seeking Alpha

Top Stories

* Rebound in Commodities Carries Stocks Higher - AP
* Report: FDIC could seek bailout from banks - AP
* BofA to face SEC trial, exits loss-sharing deal - AP
* Fed likely to keep rates near 0% for some time - CNNMoney.com
* Upgrades and Downgrades: H-P, Dell - Minyanville

Related Message Boards

* BioElectronics Corporation

Sponsored Links

*
Live Forex Practice Account
Practice Forex Trading in Real Market Conditions with a Free Trial.
www.GFTforex.com
*
Obama Urges Homeowners to Refinance
$90,000 Refinance $499/mo. See Rates- No Credit Check Req.
SeeRefinanceRates.com

*
Refinance Now at 4.25% Fixed
$160,000 Mortgage for $633/mo. Free. No obligation. Get 4 quotes.
MortgageRefinance.LendGo.com
*
Don't Pay For School - Free Scholarships
Sign Up for Free Scholarship Guide. Millions Are Available For You.
ProgramAdvisor.com/FreeScholarships...

Copyright © 2009 GlobeNewswire. All rights reserved. Redistribution of this content is expressly prohibited without prior wri

[verwijderd] 22 september 2009 16:48

De FDA aanvraag is nu officieel idd.
www.marketwatch.com/story/bioelectron...

[verwijderd] 22 september 2009 16:59

hoe lang ongveer voordat ze wat te horen krijgen?

[verwijderd] 22 september 2009 17:19

quote:
danisan schreef:
hoe lang ongveer voordat ze wat te horen krijgen?

check it out..

spreadsheets.google.com/pub?key=tO9FH...

2009-10-15 (or 12/15)

[verwijderd] 24 september 2009 10:28

eerst moeten ze nog dat ene 'kwalijke' label " Caveat Emptor " laten verwijderen op pinksheets.com

kan vandaag al zijn, of morgen

welshterrier 5 11 oktober 2009 20:34

las op google finance dat ze hier van de week nieuws verwachten, draadje maar eens even naar boven gezet.

welshterrier 5 11 oktober 2009 20:37

BioElectronics Introduces New Product for $10 Billion Dollar Veterinary Care Market
Innovative PetPatchTM Recovery Coat Meets Growing Need of Aging Pets

The HealFast PetPatch Recovery Coat lets vets and owners put the therapy right over the sore joint. Highlighted Links

BioElectronics Corp

HealFast TherapyFREDERICK, MD--(Marketwire - September 30, 2009) - BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the availability of a new product targeted at the $10 billion dollar veterinary care market, the HealFast® Therapy PetPatch™.

"There are more than a hundred and sixty million companion animals in the US alone. As they age like their baby boomer owners, arthritis and other joint issues increasingly limiting mobility," said Andrew Whelan, CEO, BioElectronics Corp. "Our portable PEMF patches reduce swelling and pain without the side effects of drugs."

"For chronic pain conditions like arthritis, we developed the HealFast RecoveryCoat™ which allows vets and owners to position the patch directly over the swollen joint without putting adhesive on the pet's fur," Whelan said.

A comprehensive direct to consumer marketing program will support the launch of the new product. The centerpiece of the campaign is a new TV commercial which will begin rolling out next week. The campaign will also engage new catalog sales.

The company said that the new durable denim coat is available in four sizes to fit breeds from the smallest to the largest. The HealFast line of patches is distributed by eMarkets Group, LLC. To learn more about HealFast or see a video of the commercial visit www.healfasttherapy.com or call 1-888 9 HEALFAST (1-888-943-2532) or 551-200-5586.

About HealFast Therapy

HealFast Therapy is a wearable patch with an embedded microchip that delivers months of

[verwijderd] 16 oktober 2009 20:32

onze bieltjes lijken ook weer een stuip omhoog te hebben.

leuk volume ook, is er iets komende of gaande, missen we iets?

[verwijderd] 20 oktober 2009 14:43

finance.yahoo.com/news/Trading-Review...

[verwijderd] 10 november 2009 18:49

De Bieltjes gaan nu weer lekker. Een duidelijke bodem op 0,057. Studieresultaten Tylenol vs Actipatch worden verwacht deze week. Vrijdag FDA meeting. Q3 cijfers volgende week (audited), met als gevolg overgang naar OTC.

Yeah Yeah,

Kijken wat de koers gaat doen tijdens deze ontwikkelingen

Demenkovets 11 november 2009 17:05

NIEUWS!! (ja echt!)

finance.yahoo.com/news/BioElectronics...

Weer boven de 8ct.

Demenkovets 11 november 2009 20:59

Ruim 20% erbij, als een stoomtrein vandaag. Maandag dus onderzoeksresultaten waar ze veel van verwachten!

978 Posts, Pagina: « 1 2 3 4 5 6 ... 39 40 41 42 43 44 45 46 47 48 49 » | Laatste

Aantal posts per pagina: 20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

AEX 882,63 +12,36 +1,42% 18:05


Germany40^	18.177,90	+1,45%
BEL 20	3.874,87	+0,44%
Europe50^	5.011,70	+1,47%
US30^	38.211,61	+0,23%
Nasd100^	17.699,84	+1,56%
US500^	5.095,29	+1,00%
Japan225^	38.345,55	+1,64%
Gold spot	2.338,88	+0,29%
EUR/USD	1,0696	-0,31%
WTI	83,64	-0,13%